Kroger agrees to pay up to $1.4 billion to settle opioid lawsuits
One of the nation’s largest grocery chains is the latest company to agree to settle lawsuits over the U.S. opioid crisis.
In a deal announced Friday, Kroger Co. will pay up to $1.4 billion over 11 years. The amount includes up to $1.2 billion for state and local governments where it operates, $36 million to Native American tribes and about $177 million to cover lawyers’ fees and costs.
Kroger has stores in 35 states — virtually everywhere save the Northeast, the northern plains and Hawaii. Thirty-three states would be eligible for money in the deal. The company previously announced settlements with New Mexico and West Virginia.
Over the last eight years, prescription drug manufacturers, wholesalers, consultants and pharmacies have proposed or finalized opioid settlements totaling more than $50 billion, including at least 12 others worth more than $1 billion. The U.S. Supreme Court is set to hear arguments later this year on whether one of the larger settlements, involving OxyContin maker Purdue Pharma, is legal.
Most of the settlement money is to be used to address an overdose epidemic linked to more than 80,000 deaths a year in the U.S. in recent years, with most of the latest deaths connected to illicit synthetic drugs such as fentanyl rather than prescription painkillers.
A settlement in the opioid trial known as MDL 2804 would be the most complex in U.S. history, with a price tag exceeding $100 billion. Where would the money go?
Still, Jayne Conroy, a lead lawyer for the governments suing the companies, told the Associated Press in an interview Friday that it makes sense for players in the prescription drug industry to have a major role in funding solutions to the crisis.
“It really isn’t a different problem,” she said. “The problem is the massive amount of addiction. That addiction stems from the massive amount of prescription drugs.”
The companies have also agreed to change their business practices regarding powerful prescription painkillers, consenting to restrictions on marketing and using data to catch overprescribing. Conroy said those noneconomic terms for Kroger have not been finalized, but they’ll look like what other companies have agreed to.
Kroger said it intends to finalize its deal in time to make initial payments in December.
The company would not admit wrongdoing or liability as part of the deal, which it called in a statement a milestone in efforts to resolve opioid lawsuits. “Kroger has long served as a leader in combating opioid abuse and remains committed to patient safety,” the company said.
Lawsuits by numerous states accused CVS, among other pharmacy chains, of helping to fuel the opioid crisis by filling prescriptions that should have been flagged as inappropriate.
Although most of the biggest players have settled, the opioid litigation is continuing. Cases are being prepared for trial involving the supermarket chains Publix and Albertsons, the latter of which is attempting to merge with Kroger. Pharmacy benefit managers such as Express Scripts and OptumRx also face opioid claims from governments.
